- Appearance:Crystalline Solid
Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.
|Handling||Protect from air and moisture|
|UN #'S||Not Applicable|
|Packing Group||Not Applicable|